We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medicare Snag Could Slow Uptake of First Drug-Coated Balloon for Legs
Medicare Snag Could Slow Uptake of First Drug-Coated Balloon for Legs
Bard’s Lutonix cleared the FDA hurdle, making it the first drug-coated angioplasty balloon catheter to treat peripheral artery disease in the leg approved for use in the U.S. But it could be another year or more before the technology wins over payers.